AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-95 |
Results: 76-95/95
A DOSE-INTENSIVE REGIMEN OF DAUNORUBICIN AND CYTARABINE AS THE INITIAL PHASE OF THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA IN BLAST CRISIS
Authors: KOUIDES PA ROWE JM
Citation: Pa. Kouides et Jm. Rowe, A DOSE-INTENSIVE REGIMEN OF DAUNORUBICIN AND CYTARABINE AS THE INITIAL PHASE OF THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA IN BLAST CRISIS, Blood, 84(10), 1994, pp. 10000147-10000147
FAVORABLE OUTCOME FOR OLDER ADULTS RECEIVING AUTOTRANSPLANTS FOR RELAPSED REFRACTORY LYMPHOMA
Authors: RAPOPORT AP DIPERSIO JF DUERST RE LIESVELD JL ABBOUD CN PACKMAN CH EBERLY SW TANNER MA ROWE JM
Citation: Ap. Rapoport et al., FAVORABLE OUTCOME FOR OLDER ADULTS RECEIVING AUTOTRANSPLANTS FOR RELAPSED REFRACTORY LYMPHOMA, Blood, 84(10), 1994, pp. 10000164-10000164
CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY ROQUINIMEX
Authors: ROWE JM RYAN DH NILSSON BI LIESVELD JL DIPERSIO JF RAPOPORT AP ABBOUD CN LARSSON L PACKMAN CH DUERST RE SIMONSSON B
Citation: Jm. Rowe et al., CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY ROQUINIMEX, Blood, 84(10), 1994, pp. 10000204-10000204
USE OF GVHD PROPHYLAXIS WITH CONTINUOUS-INFUSION CYCLOSPORINE-A, NIFEDIPINE, METHOTREXATE, AND STEROIDS IN MATCHED UNRELATED DONOR TRANSPLANTS (MUDS)
Authors: LIESVELD JL PACKMAN CH ABBOUD CN DIPERSIO JF RAPOPORT AP MARTIN BA YIRINEC BA FLESCHER WR SILVERMAN WA CONSTINE LS ROWE JM DUERST RE
Citation: Jl. Liesveld et al., USE OF GVHD PROPHYLAXIS WITH CONTINUOUS-INFUSION CYCLOSPORINE-A, NIFEDIPINE, METHOTREXATE, AND STEROIDS IN MATCHED UNRELATED DONOR TRANSPLANTS (MUDS), Blood, 84(10), 1994, pp. 10000341-10000341
MULTIDRUG-RESISTANCE GENE (MDR-1) TRANSCRIPT OR CD34 ANTIGEN EXPRESSION LEVELS DO NOT PREDICT FOR COMPLETE REMISSIONS IN DE-NOVO ADULT ACUTE MYELOID-LEUKEMIA (AML) - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY
Authors: PAIETTA E ANDERSEN J RACEVSKIS J BENNETT J ROWE JM CASSILETH P WIERNIK PH
Citation: E. Paietta et al., MULTIDRUG-RESISTANCE GENE (MDR-1) TRANSCRIPT OR CD34 ANTIGEN EXPRESSION LEVELS DO NOT PREDICT FOR COMPLETE REMISSIONS IN DE-NOVO ADULT ACUTE MYELOID-LEUKEMIA (AML) - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, Blood, 84(10), 1994, pp. 10000377-10000377
EARLY THERAPY WITH GANCICLOVIR (DHPG) FOR CYTOMEGALOVIRUS (CMV) INFECTION - A REPORT OF AN OUTPATIENT-BASED REGIMEN IN 102 CONSECUTIVE ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) PROCEDURES
Authors: MARTIN BA ROWE JM DUERST RE RAPOPORT AP LIESVELD JL PACKMAN CH DIPERSIO JF
Citation: Ba. Martin et al., EARLY THERAPY WITH GANCICLOVIR (DHPG) FOR CYTOMEGALOVIRUS (CMV) INFECTION - A REPORT OF AN OUTPATIENT-BASED REGIMEN IN 102 CONSECUTIVE ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) PROCEDURES, Blood, 84(10), 1994, pp. 10000486-10000486
NON-RELAPSE MORTALITY AND EVENT-FREE SURVIVAL RATES AFTER ALLO-BMT FOR ADULTS GREATER-THAN-OR-EQUAL-TO-AGE-40 ARE COMPARABLE TO THOSE OF PATIENTS LESS-THAN-AGE-40
Authors: RAPOPORT AP DIPERSIO JF DUERST RE LIESVELD JL MARTIN BA YIRINEC BA ABBOUD CN PACKMAN CH EBERLY SW TANNER MA ROWE JM
Citation: Ap. Rapoport et al., NON-RELAPSE MORTALITY AND EVENT-FREE SURVIVAL RATES AFTER ALLO-BMT FOR ADULTS GREATER-THAN-OR-EQUAL-TO-AGE-40 ARE COMPARABLE TO THOSE OF PATIENTS LESS-THAN-AGE-40, Blood, 84(10), 1994, pp. 10000719-10000719
ARE PROTECTED ENVIRONMENTS NECESSARY FOR RECIPIENTS OF BONE-MARROW TRANSPLANTS - RESPONSE
Authors: ROWE JM LAZARUS HM
Citation: Jm. Rowe et Hm. Lazarus, ARE PROTECTED ENVIRONMENTS NECESSARY FOR RECIPIENTS OF BONE-MARROW TRANSPLANTS - RESPONSE, Annals of internal medicine, 121(1), 1994, pp. 76-76
RECOMMENDED GUIDELINES FOR THE MANAGEMENT OF AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REPORT FROM THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG)
Authors: ROWE JM CIOBANU N ASCENSAO J STADTMAUER EA WEINER RS SCHENKEIN DP MCGLAVE P LAZARUS HM
Citation: Jm. Rowe et al., RECOMMENDED GUIDELINES FOR THE MANAGEMENT OF AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REPORT FROM THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG), Annals of internal medicine, 120(2), 1994, pp. 143-158
ASPECTS OF THE SYNTHESIS, CHARACTERIZATION AND METAL-LIGAND STOICHIOMETRY OF AMINOPROPYL, NITROBENZAMIDE, AND 8-QUINOLINOL SILICA-GELS
Authors: JEZOREK JR TANG JW COOK WL OBIE R JI DJ ROWE JM
Citation: Jr. Jezorek et al., ASPECTS OF THE SYNTHESIS, CHARACTERIZATION AND METAL-LIGAND STOICHIOMETRY OF AMINOPROPYL, NITROBENZAMIDE, AND 8-QUINOLINOL SILICA-GELS, Analytica chimica acta, 290(3), 1994, pp. 303-315
TREATMENT OF MINIMAL RESIDUAL DISEASE IN MYELOID-LEUKEMIA - THE IMMUNOTHERAPEUTIC OPTIONS WITH EMPHASIS ON LINOMIDE
Authors: ROWE JM NILSSON BI SIMONSSON B
Citation: Jm. Rowe et al., TREATMENT OF MINIMAL RESIDUAL DISEASE IN MYELOID-LEUKEMIA - THE IMMUNOTHERAPEUTIC OPTIONS WITH EMPHASIS ON LINOMIDE, Leukemia & lymphoma, 11(5-6), 1993, pp. 321-329
ABO AND PLATELET TRANSFUSION REVISITED
Authors: HEAL JM ROWE JM BLUMBERG N
Citation: Jm. Heal et al., ABO AND PLATELET TRANSFUSION REVISITED, Annals of hematology, 66(6), 1993, pp. 309-314
100 AUTOTRANSPLANTS FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE AND LYMPHOMA - VALUE OF PRETRANSPLANT DISEASE STATUS FOR PREDICTING OUTCOME
Authors: RAPOPORT AP ROWE JM KOUIDES PA DUERST RA ABBOUD CN LIESVELD JL PACKMAN CH EBERLY S SHERMAN M TANNER MA CONSTINE LS DIPERSIO JF
Citation: Ap. Rapoport et al., 100 AUTOTRANSPLANTS FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE AND LYMPHOMA - VALUE OF PRETRANSPLANT DISEASE STATUS FOR PREDICTING OUTCOME, Journal of clinical oncology, 11(12), 1993, pp. 2351-2361
TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH AUTOLOGOUS BONE-MARROWTRANSPLANTATION FOLLOWED BY THE IMMUNOMODULATOR ROQUINIMEX (LINOMIDE)
Authors: ROWE JM RYAN DH DIPERSIO JF NILSSON BI LARSSON L SIMONSSON B
Citation: Jm. Rowe et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH AUTOLOGOUS BONE-MARROWTRANSPLANTATION FOLLOWED BY THE IMMUNOMODULATOR ROQUINIMEX (LINOMIDE), Experimental hematology, 21(8), 1993, pp. 1020-1020
THE CHANGING COURSE OF THROMBOTIC THROMBOCYTOPENIC PURPURA AND MODERNTHERAPY
Authors: ROSE M ROWE JM ELDOR A
Citation: M. Rose et al., THE CHANGING COURSE OF THROMBOTIC THROMBOCYTOPENIC PURPURA AND MODERNTHERAPY, Blood reviews, 7(2), 1993, pp. 94-103
TQM IN SYSTEM-DEVELOPMENT - A PARADIGM WITHOUT A SOUND FOUNDATION
Authors: ROWE JM NEAL RD
Citation: Jm. Rowe et Rd. Neal, TQM IN SYSTEM-DEVELOPMENT - A PARADIGM WITHOUT A SOUND FOUNDATION, Journal of systems management, 44(5), 1993, pp. 12-16
MOLECULAR-CLONING AND EXPRESSION OF HUMAN NMDA RECEPTOR SUBUNITS
Authors: LEBOURDELLES B WAFFORD KA GRIMWOOD S ROWE JM KEMP JA RAGAN CI WHITING PJ
Citation: B. Lebourdelles et al., MOLECULAR-CLONING AND EXPRESSION OF HUMAN NMDA RECEPTOR SUBUNITS, Journal of neurochemistry, 61, 1993, pp. 190000010-190000010
MOLECULAR-CLONING AND EXPRESSION OF HUMAN NMDA RECEPTOR SUBUNITS
Authors: LEBOURDELLES B WAFFORD KA GRIMWOOD S ROWE JM KEMP JA RAGAN CI WHITING PJ
Citation: B. Lebourdelles et al., MOLECULAR-CLONING AND EXPRESSION OF HUMAN NMDA RECEPTOR SUBUNITS, Journal of neurochemistry, 61, 1993, pp. 190000256-190000256
CIRCULATING IMMUNE-COMPLEXES INVOLVING THE ABO SYSTEM AFTER PLATELET TRANSFUSION
Authors: HEAL JM MASEL D ROWE JM BLUMBERG N
Citation: Jm. Heal et al., CIRCULATING IMMUNE-COMPLEXES INVOLVING THE ABO SYSTEM AFTER PLATELET TRANSFUSION, British Journal of Haematology, 85(3), 1993, pp. 566-572
PHASE-III RANDOMIZED PLACEBO-CONTROLLED STUDY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN ADULT PATIENTS (55-70 YEARS) WITH ACUTE MYELOGENOUS LEUKEMIA (AML) - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG)
Authors: ROWE JM ANDERSEN J MAZZA JJ PAIETTA E BENNETT JM HAYES A OETTE D WIERNIK PH
Citation: Jm. Rowe et al., PHASE-III RANDOMIZED PLACEBO-CONTROLLED STUDY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN ADULT PATIENTS (55-70 YEARS) WITH ACUTE MYELOGENOUS LEUKEMIA (AML) - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG), Blood, 82(10), 1993, pp. 10000329-10000329
Risultati: 1-25 | 26-50 | 51-75 | 76-95 |